Delivery Order SPE2DB25D3008-SPE2DB25FRDAS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,259.50 to AmerisourceBergen Drug Corp for 60 units of Scemblix 40 mg tablets, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a single transaction under the company's larger pharmaceutical supply relationship with the federal government. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major...
- The Defense Logistics Agency awarded a $13,259.50 delivery order to AmerisourceBergen Drug Corp for Scemblix 40 mg tablets (60-count units) on August 8, 2025, with an ultimate completion date of August 29, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a $13,259.50 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Scemblix 40 mg tablets (60-count units). This competitively awarded, non-set-aside contract is scheduled for completion by September 9, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has...
- The Defense Logistics Agency awarded a $13,259.50 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Scemblix 40 mg tablets in quantities of 60 units. This firm fixed-price, competitively awarded contract with no set-aside designation is scheduled for completion by August 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Scemblix is a prescription medication used in the treatment of chronic myeloid...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $53,038 on August 20, 2025, for the supply of SCEMBLIX 40 mg tablets (60-count units) under a firm fixed-price contract with no set-aside designation. The order, which carries an ultimate completion date of September 11, 2025, is funded through the Defense Logistics Agency's Medical Supply Chain and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency for SCEMBLIX 40 mg tablets in a quantity of 60 units. The contract, issued on August 20, 2025, carries a ceiling value of $13,259.50 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 11, 2025. This award was made without a set-aside designation, indicating it was competitively...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 31, 2025, for SCEMBLIX 40 mg tablets in quantities of 60 units. The contract is valued at $13,259.50 under a firm fixed-price arrangement with a completion date of August 21, 2025. This award represents a competitive procurement with no set-aside designation and serves as a child contract under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,572.06 firm fixed-price delivery order covers the supply of SCEMBLIX 40 MG TABLET medical products, with a completion date of December 27, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award, valued at $24,304.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the drug product SCEMBLIX 40 MG TABLET. It is a firm-fixed-price contract with a completion date of November 25, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $24,304.14 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of SCEMBLIX 40 MG TABLET UU 60S pharmaceutical product. This delivery order contract has an ultimate completion date of April 11, 2024. AmerisourceBergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order is placed against an indefinite...
- SPE2DB25D3008Indefinite Delivery Contract
- SPE2DB25D3008-SPE2DB25FRDASDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $13,259.50 to AmerisourceBergen Drug Corp for the supply of Scemblix 40 mg tablets (60-count units) under a firm fixed-price contract. The order, issued on August 22, 2025, with an ultimate completion date of September 15, 2025, represents a competitively awarded, non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's comprehensive pharmaceutical prime vendor agreement with the Defense Logistics Agency, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a broad spectrum of pharmaceutical products and medical supplies to support military and veteran healthcare systems worldwide. The Scemblix order fulfills medical supply requirements within the company's extensive portfolio of brand-name and generic medications across multiple therapeutic domains, supporting the Defense Health Agency and other federal healthcare customers through this flexible and comprehensive contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.3k | 8/22/25 |